|
The First nine months of this year they added a total of 34 million shares and most were added at a much higher price.
This last quarter they filed they added no shares at all and that leaves only 34 million shares ever sold below or at the pennies mark.
Most of the down volume this year has been on light shares and it is ready to race back up to at the least .005 this first quarter.
Company has not set a precedent of selling many shares and there are no filings suggesting any shares are really ready for sales.
I think most of the large owners will not do anything but buy shares from here back to the penny.
I have the shares listed below now and I also have the insiders shares on the last ten-k report.
It is close to what they have on the market and chart suggest they are much higher then a penny now for those shares.
It is just a matter of time we are back in the penny this new year and this next week we should test the .003 with a .0025 break in the picture.
There are over 51% or over 600 million shares owned by directors.
When they did the reverse merger at the higher price they sold 232 million shares to the market and investors in 2011.
They then added the 500 million shares also for the reverse for the new company.
I figure there are another 200 million shares tied up with the large buyers and I look for there only to be 30 to 40 million shares sold below the penny now.
Also note the Sysco has some shares and a contract to sell the service to there chain.
Huge Re-seller there with Sysco Icare selling to restaurants bars and other customers. They have a huge distribution across the whole US and will roll it out as the company can grow.
Below is the break down report of total shares and below that is the weekly chart for the year.
As of September 30, 2012, there were 1,202,889,520 shares of the Registrant's Common Stock outstanding.
On April 1, 2011, the Company entered into an agreement with iCare Marketing, Inc. (“iCare), a wholly owned subsidiary of Sysco Corporation (“Sysco”), whereby iCare will promote the Company’s product to Sysco’s customers. Under the agreement, the Company is committed to pay 5% of the gross revenues received from any Sysco customer, an integration fee, $250 per trade show event attended by the Company and an amount to be determined for additional promotions and marketing programs. The Company paid $50,000 of the integration fee in cash and the balance by issuing 15,861,372 shares of common stock which were valued at $22,205, using a price per share of $.0014, , which is the price per share applicable to the October 2011 issuances described in Note 5, above.. The integration fee has been recorded at $72,205 and is being amortized over the four-year life of the agreement. $16,765 has been recorded for amortization of the agreement during the year ended December 31, 2011.
As of September 30, 2012, there were 1,202,889,520 shares of the Registrant's Common Stock outstanding.
|
Name and Address
of Beneficial Owner
|
|
Nature and Amount
of Beneficial Ownership
of Common Stock
|
|
Percentage of Ownership 1
|
| |
|
|
|
|
|
Mark E. Astrom 2
|
|
5,000
|
|
0%
|
|
Christopher Carey
|
|
143,327,787
|
|
12.26%
|
|
Christopher Carey, Jr.
|
|
160,527,121 3
|
|
13.74%
|
|
Mary Weaver Carey
|
|
315,321,131 4
|
|
26.98%
|
|
Blazej Kesy
|
|
143,327,787
|
|
12.26%
|
|
All directors and executive
officers as a group (3 persons)
|
|
601,981,705
|
|
51.50%
|
1 0k report this last year. and we are nine m onths reported above
EYES ON THE GO, INC.
STATEMENT OF STOCKHOLDERS’ DEFICIENCY
| |
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
|
|
|
|
|
| |
|
COMMON STOCK
|
|
|
Paid-In
|
|
|
Subscription
|
|
|
Accumulated
|
|
|
|
|
| |
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Receivable
|
|
|
Deficit
|
|
|
Total
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE – August 26, 2010 (Inception)
|
|
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued to founders
|
|
|
360,000,000
|
|
|
|
360
|
|
|
|
(360
|
)
|
|
|
|
|
|
|
-
|
|
|
|
-
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Contribution
|
|
|
|
|
|
|
|
|
|
|
30,500
|
|
|
|
|
|
|
|
|
|
|
|
30,500
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
|
|
|
|
|
|
|
Scroll down for more posts ▼
Top 10 Most Recent News Articles
NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...
Continue Reading
FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...
Continue Reading
Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...
Continue Reading
An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...
Continue Reading
A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...
Continue Reading
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...
Continue Reading
Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...
Continue Reading
Top 5 Most Recently Viewed Articles
Eli Lilly's New Ventures to Boost Drug Development Eli Lilly and Co (NYSE: LLY) has announced a significant investment of $4.5 billion for establishing the Lilly Medicine Foundry, a cutting-edge research and manufacturing facility. This initiative aims to enhance the company's drug pipeline and facilitate faster delivery of treatments to the market. The investment is a...
Continue Reading
Innovative Machinery Companies Selected for Global Support Program The Korea Innovation Foundation (INNOPOLIS) has recently announced the selection of three innovative machinery companies for its Global Technology Commercialization Support Program. The companies chosen are ARA, Korea Intelligence Machine, and Moqous, each recognized for their unique contributions to...
Continue Reading
Understanding Oracle's Position in the Software Industry In the bustling and ever-evolving world of technology, staying informed about company dynamics is more crucial than ever. For both investors and enthusiasts, comprehensively analyzing players like Oracle (NYSE: ORCL) can unveil significant insights. This article embarks on a detailed exploration of Oracle's...
Continue Reading
Sono-Tek Secures Major Order in Medical Device Sector Sono-Tek Corporation, a leading name in ultrasonic coating systems, has recently announced an impressive order worth over $2.8 million from a notable medical device manufacturer. This order signifies the trust and confidence that industry leaders place in Sono-Tek as they enhance their production capabilities. Details...
Continue Reading
Moderna's Sales Decline: A Closer Look This past week, Moderna Inc. (NASDAQ: MRNA) experienced a setback as it reported its fourth-quarter earnings, highlighting a significant loss in earnings per share (EPS). The company posted an EPS loss of $(2.91), which fell short of the projected $(2.62) and marked a downturn from a positive EPS of $0.55 in the same quarter last...
Continue Reading
| |
